Promising New Ra Drug In Phase 3 Trial


Clinical Trials For Disease Modifying Therapies In Alzheimer S Disease A Primer Lessons Learned And A Blueprint For The Future Abstract Europe Pmc


Safety And Immunogenicity Of The Tetravalent Live Attenuated Dengue Vaccine Butantan Dv In Adults In Brazil A Two Step Double Blind Randomised Placebo Controlled Phase 2 Trial The Lancet Infectious Diseases


Efficacy And Safety Of Abrocitinib In Adults And Adolescents With Moderate To Severe Atopic Dermatitis Jade Mono 1 A Multicentre Double Blind Randomised Placebo Controlled Phase 3 Trial The Lancet


Cobitolimod For Moderate To Severe Left Sided Ulcerative Colitis Conduct A Phase 2b Randomised Double Blind Placebo Controlled Dose Ranging Induction Trial The Lancet Gastroenterology Hepatology


Kinase Drug Discovery 20 Years After Imatinib Progress And Future Directions Nature Reviews Drug Discovery


Http Www Medicinainterna Net Pe Sites Default Files Avances 20en 20el 20manejo 20de 20la 20artritis 20 20reumatoidea Pdf


Janus Kinase Inhibitors Offer New Treatment For Rheumatoid Arthritis Psoriatic Arthritis Colitis


Ngr Htnf In Combination With Best Investigator Choice In Previously Treated Malignant Pleural Mesothelioma Ngr015 A Randomised Double Blind Placebo Controlled Phase 3 Trial The Lancet Oncology


Targeting Emt In Cancer With Repurposed Metabolic Inhibitors Trends In Cancer


Efficacy Of Three Neuroprotective Drugs In Secondary Progressive Multiple Sclerosis Ms Smart A Phase 2b Multiarm Double Blind Randomised Placebo Controlled Trial The Lancet Neurology


Efficacy And Safety Of Abrocitinib In Adults And Adolescents With Moderate To Severe Atopic Dermatitis Jade Mono 1 A Multicentre Double Blind Randomised Placebo Controlled Phase 3 Trial The Lancet


Recent Updates In The Clinical Trials Of Therapeutic Monoclonal Antibodies Targeting Cytokine Storm For The Management Of Covid 19 Sciencedirect


Efficacy And Safety Of Tisotumab Vedotin In Previously Treated Recurrent Or Metastatic Cervical Cancer Innovatv 204 Gog 3023 Engot Cx6 A Multicentre Open Label Single Arm Phase 2 Study The Lancet Oncology


Supplemental Materials For Momelotinib Versus Best Available Therapy In Patients With Myelofibrosis Previously Treated With Ruxolitinib Simplify 2 A Randomised Open Label Phase 3 Trial The Lancet Haematology


Phase Iii Randomized Trial Of Mirvetuximab Soravtansine Versus Chemotherapy In Patients With Platinum Resistant Ovarian Cancer Primary Analysis Of Forward I Annals Of Oncology


Use Of Ribaxamase Syn 004 A B Lactamase To Prevent Clostridium Difficile Infection In B Lactam Treated Patients A Double Blind Phase 2b Randomised Placebo Controlled Trial The Lancet Infectious Diseases


Efficacy Of Three Neuroprotective Drugs In Secondary Progressive Multiple Sclerosis Ms Smart A Phase 2b Multiarm Double Blind Randomised Placebo Controlled Trial The Lancet Neurology


A Two Arm Randomized Controlled Multi Centric Open Label Phase 2 Study To Evaluate The Efficacy And Safety Of Itolizumab In Moderate To Severe Ards Patients Due To Covid 19 Medrxiv


Lenvatinib In Patients With Advanced Or Metastatic Thymic Carcinoma Remora A Multicentre Phase 2 Trial The Lancet Oncology


Long Term Effect Of Tocilizumab In Patients With Giant Cell Arteritis Open Label Extension Phase Of The Giant Cell Arteritis Actemra Giacta Trial The Lancet Rheumatology

Leave a Reply

Your email address will not be published. Required fields are marked *